Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hemodynamic Effects of Angiotensin Receptor Neprilysin Inhibition on Noninvasive Pressure-volume Analysis in Patients With Heart Failure With Reduced Ejection Fraction

NCT04498780 is registered in ClinicalTrials.gov with University of Leipzig as lead sponsor.

NCT NCT04498780
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04498780 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hemodynamic Effects of Angiotensin Receptor Neprilysin Inhibition on Noninvasive Pressure-volume Analysis in Patients With Heart Failure With Reduced Ejection Fraction
Lead sponsor
University of Leipzig
Phase
Observational
Overall status
Completed
Start date
July 21, 2020
Completion date
April 8, 2026
Enrollment
117 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure with reduced ejection fraction